CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ogiso, Y.
Right arrow Articles by Shih, T. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ogiso, Y.
Right arrow Articles by Shih, T. Y.

Cell Growth & Differentiation, Vol 1, Issue 5 217-224, Copyright © 1990 by American Association of Cancer Research


ARTICLES

trans-Dominant suppressor mutations of the H-ras oncogene

Y Ogiso, L Gutierrez, LS Wrathall, YY Lu, DG Blair, DJ Clanton, YW Hwang and TY Shih
Laboratory of Molecular Oncology, National Cancer Institute, Frederick, Maryland 21701-1013.

Site-directed mutagenesis of the conserved sequence motifs of p21 generated a group of mutant p21s defective in GTP binding. Some of these mutants were highly transforming, whereas others were transformation defective. Among the latter group, we found two mutants, derived from the v-H-ras oncogene by substituting the asparagine-116 with tyrosine and isoleucine, that exhibited a trans-dominant activity of suppressing the transformed phenotype of NIH3T3 cells induced by a long terminal repeat-linked c-H-ras and a wild-type v-H-ras. They caused reduction of the colony-forming efficiency in soft agar (78% in c-ras-transformed cells; 55% in v-ras cells) and morphological reversion of ras transformants. Subclones of revertants expressed a great excess of mutant p21 relative to the c-ras p21 present in these cells. These mutants were not lethal to NIH3T3 cells. Apparently, defective proteins encoded by suppressor mutants sequestered vital targets for ras function. Suppressor mutants also induced morphological reversion of NIH3T3 cells transformed by src, fes/flp, sis, and fms oncogenes, suggesting that these oncogenes function upstream to ras in the signaling pathways. Cells transformed by mos and a chemical carcinogen were unaffected.


This article has been cited by other articles:


Home page
J Biol ChemHome page
Y.-J. Sung, M.-C. C. Hwang, and Y.-W. Hwang
The Dominant Negative Effects of H-Ras Harboring a Gly to Ala Mutation at Position 60
J. Biol. Chem., November 29, 1996; 271(48): 30537 - 30543.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
M Benito, A Porras, A. Nebreda, and E Santos
Differentiation of 3T3-L1 fibroblasts to adipocytes induced by transfection of ras oncogenes
Science, August 2, 1991; 253(5019): 565 - 568.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1990 by the American Association of Cancer Research.